Carole Bradley-Kennedy

Director, Health Economics, Pricing and Outcomes Research

All Sessions by Carole Bradley-Kennedy

Printer Friendly See Full Agenda

Day 1: Feb 9, 2021

5:00 pm

5:00 pm

New PMPRB Regulations: Impact on industry, marketing and digital

In August 2019, the Patented Medicines Pricing Review Board (PMPRB) amended Regulations that will have a significant impact on the future of Canadian pharmaceutical companies, Canada’s life sciences sector and ultimately patients.  The amended Regulations will drop drug ceiling prices by up to 70%, which will create a significant dis-incentive for future investment.

This talk will discuss how these changes will impact the pharma industry after they go into effect on July 1st 2020 including:

  • The potential impact on current products and future drug launches
  • The impact to customers, including payers, physicians and patients
  • The impact on marketing as we strive for customer-centric solutions and to be a valued partner in healthcare

Understand how the new PMPRB regulations will impact the pharma industry and how companies will need to adapt and transform

Day 2: Feb 10, 2021